Exhibit 23.3
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated February 27, 2025, with respect to the consolidated financial statements of Pfizer Inc. and Subsidiary Companies, and the effectiveness of internal control over financial reporting, incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.
| /s/ KPMG LLP |
New York, New York
May 9, 2025